Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes

Biomarkers in Medicine

Volumn 5, Issue 6, 2011, Pages 827-835

  Son, Jang Won ^a   Jang, Eun Hee ^b   Kim, Mee Kyoung ^b   Baek, Ki Hyun ^b   Song, Ki Ho ^b   Yoon, Kun Ho ^c   Cha, Bong Yun ^c   Son, Ho Young ^c   Lee, Kwang Woo ^b   Jo, Hanjoong ^d   Kwon, Hyuk Sang ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; BMP; cardio ankle vascular index; ccarotid intima media thickness

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; C REACTIVE PROTEIN; FATTY ACID; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL PARAMETERS; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD PRESSURE; BONE MORPHOGENETIC PROTEIN 4; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; TRIGLYCERIDES; VASCULAR STIFFNESS;

EID: 82755166891     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.81     Document Type: Article

References (31)

1. Kharlip J, Naglieri R, Mitchell BD, Ryan KA, Donner TW. Screening for silent coronary heart disease in Type 2 diabetes: clinical application of American Diabetes Association guidelines. Diabetes Care 29(3), 692-694 (2006). (Pubitemid 44115375)
2. Bax JJ, Young LH, Frye RL et al. Screening for coronary artery disease in patients with diabetes. Diabetes Care 30(10), 2729-2736 (2007). (Pubitemid 47547828)
3. Kathiresan S, Larson MG, Keyes MJ et al. Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am. J. Cardiol. 99(3), 310-314 (2007). (Pubitemid 46149547)
4. De Jager J, Dekker JM, Kooy A et al. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with Type 2 diabetes: the Hoorn Study. Arterioscler. Thromb. Vasc. Biol. 26(5), 1086-1093 (2006). (Pubitemid 43732116)
5. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 290(7), 932-940 (2003). (Pubitemid 37430466)
6. Hodis HN, Mack WJ, LaBree L et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med. 128(4), 262-269 (1998). (Pubitemid 28090756)
7. Nakamura U, Iwase M, Nohara S et al. Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens. Res. 26(2), 163-167 (2003). (Pubitemid 36372336)
8. Yambe T, Yoshizawa M, Saijo Y et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed. Pharmacother. 58(Suppl. 1), S95-S98 (2004). (Pubitemid 40979629)
9. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann. NY Acad. Sci. 902, 230-239 (2000).
10. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
11. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 5(3), 293-302 (1985). (Pubitemid 15098005)
12. Sorescu GP, Sykes M, Weiss D et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J. Biol. Chem. 278(33), 31128-31135 (2003). (Pubitemid 36994628)
13. Csiszar A, Labinskyy N, Smith KE et al. Downregulation of bone morphogenetic protein 4 expression in coronary arterial endothelial cells: role of shear stress and the cAMP/protein kinase A pathway. Arterioscler. Thromb. Vasc. Biol. 27(4), 776-782 (2007). (Pubitemid 46606706)
14. Cui Y, Jean F, Thomas G, Christian JL. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J. 17(16), 4735-4743 (1998). (Pubitemid 28377173)
15. Constam DB, Robertson EJ. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell. Biol. 144(1), 139-149 (1999). (Pubitemid 29047017)
16. Chang K, Weiss D, Suo J et al. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 116(11), 1258-1266 (2007). (Pubitemid 47517537)
17. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J. Thromb. Haemost. 1(1), 178-185 (2003).
18. Sun J, Zhuang FF, Mullersman JE et al. BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction. J. Biol. Chem. 281(39), 29349-29356 (2006). (Pubitemid 44507078)
19. Miriyala S, Gongora Nieto MC, Mingone C et al. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113(24), 2818-2825 (2006). (Pubitemid 44305294)
20. San Martin A, Du P, Dikalova A et al. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 292(5), 2073-2082 (2007).
21. Bostrom KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ. Res. 108(4), 446-457 (2011).
22. Son JW, Kim MK, Park YM et al. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals. Endocr. J. 58(1), 39-46 (2010).
23. Izuhara M, Shioji K, Kadota S et al. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ. J. 72(11), 1762-1767 (2008).
24. Takaki A, Ogawa H, Wakeyama T et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ. J. 71(11), 1710-1714 (2007). (Pubitemid 350240090)
25. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 28(12), 1462-1536 (2007).
26. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J. Atheroscler. Thromb. 13(2), 101-107 (2006).
27. Kanazawa I, Yamaguchi T, Yamamoto M et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in Type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 94(1), 45-49 (2009).
28. Austin MA, McKnight B, Edwards KL et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101(24), 2777-2782 (2000). (Pubitemid 30396006)
29. Sarti C, Gallagher J. The metabolic syndrome: prevalence, CHD risk, and treatment. J. Diabetes Complications 20(2), 121-132 (2006).
30. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and Type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 111(3), 121-124 (2003). (Pubitemid 36682048)
31. Taniguchi A, Sakai M, Teramura S et al. Serum nonesterified fatty acids are related with carotid atherosclerotic plaque in nonobese nonhypertensive Japanese Type 2 diabetic patients. Diabetes Care 24(8), 1505-1507 (2001).